Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...
Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...
Nat Clin Pract Neurol. 2006;2(9):482-493.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback